Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 50675-18-8 | MDL No. : | MFCD03425264 |
Formula : | C6H10O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CXLGNJCMPWUZKM-UHFFFAOYSA-N |
M.W : | 114.14 | Pubchem ID : | 9964078 |
Synonyms : |
|
Num. heavy atoms : | 8 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.83 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 30.13 |
TPSA : | 26.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.97 cm/s |
Log Po/w (iLOGP) : | 1.36 |
Log Po/w (XLOGP3) : | 0.03 |
Log Po/w (WLOGP) : | 0.61 |
Log Po/w (MLOGP) : | 0.07 |
Log Po/w (SILICOS-IT) : | 1.58 |
Consensus Log Po/w : | 0.73 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -0.5 |
Solubility : | 36.0 mg/ml ; 0.316 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.13 |
Solubility : | 83.7 mg/ml ; 0.733 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.67 |
Solubility : | 24.5 mg/ml ; 0.214 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.48 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P301+P312-P302+P352-P304+P340-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61% | Stage #1: With 2,2,6,6-tetramethyl-piperidine-N-oxyl; sodium hydrogencarbonate; potassium bromide In dichloromethane; water at 4℃; Stage #2: With sodium hypochlorite; chlorine In dichloromethane; water at 4 - 20℃; for 17.4 h; |
To 5.00 g (43.0 mmol) of (tetrahydro-pyran-yl)-methanol in DCM (50 mL) are added 67 mg of 2,2,6,6-tetramethyl-1-piperidinyloxy (0.43 mmol), a solution of 9.04 g (108 mmol) NaHCO3 in water (70 mL) and 512 mg (4.30 mmol) of potassium bromide at 20° C. The suspension is cooled in an ice bath to 4° C. Then a solution of 23.5 mL sodium hypochlorite (10-15percent free chlorine; 47.4 mmol) is added in 35 min. The suspension is stirred for 30 min at 4-9° C. and further 45 min to reach 17° C. 4.80 mL sodium hypochlorite (10-15percent free chlorine) is added within 15 min. The reaction is stirred for 16 h at RT. The suspension is filtered and the layers are separated. The aq. layer is washed with 50 mL DCM, the combined organic layers are washed with 50 mL water. The solvent is removed under reduced pressure to afford 3.00 g of tetrahydro-pyran-4-carbaldehyde. Yield: 61percent; ESI-MS: 113 [M+H]- |
61% | With sodium hypochlorite; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; sodium hydrogencarbonate; potassium bromide In dichloromethane; water at 4 - 20℃; for 18.0833 h; | To 5.00 g (43.0 mmol) of (tetrahydro-pyran-yl)-methanol in DCM (50 mL) are added 67 mg of 2,2,6,6-tetramethyl-1 -piperidinyloxy (0.43 mmol), a solution of 9.04 g (108 mmol) NaHC03 in water (70 mL) and 512 mg (4.30 mmol) of potassium bromide at 20 °C. The suspension is cooled in an ice bath to 4 °C. Then a solution of 23.5 mL sodium hypochlorite (10-15percent free chlorine; 47.4 mmol) is added in 35 min. The suspension is stirred for 30 min at 4-9 °C and further 45 min to reach 17 °C. 4.80 mL sodium hypochlorite (10-15percent free chlorine) is added within 15 min. The reaction is stirred for 16 h at RT. The suspension is filtered and the layers are separated. The aq. layer is washed with 50 mL DCM, the combined organic layers are washed with 50 mL water. The solvent is removed under reduced pressure to afford 3.00 g of tetrahydro-pyran-4-carbaldehyde. Yield: 61 percent; ESI-MS: 1 13 [M+H]" |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
52% | Stage #1: With diisobutylaluminium hydride In toluene at -78℃; for 1 h; Stage #2: With water; ammonium chloride In toluene |
Reference Example 2: Tetrahydropyran-4-carbaldehyde. To a solution of tetrahydro pyran-4-carbonitrile (1.0 g, 9.0 mmol) in toluene (10 mL) was added diisobutylaluminium hydride solution (DIBAL-H, 10.8 mL, 10.8 mrnol,10 IM in toluene) at -78°C. The reaction was stirred at -780C for 1 hour then allowed to warm to r.t. The reaction was quenched with saturated ammonium chloride solution and extracted with ethyl acetate. The combined organics were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure to afford tetrahydropyran-4-carb aldehyde (530 mg, 52 percent). |
[ 20417-61-2 ]
Ethyl 2-formylcyclopropanecarboxylate
Similarity: 0.69
[ 54274-80-5 ]
trans-Methyl 4-formylcyclohexanecarboxylate
Similarity: 0.68
[ 94994-25-9 ]
Methyl 4-formylbicyclo[2.2.2]octane-1-carboxylate
Similarity: 0.66
[ 137052-08-5 ]
1-(Tetrahydro-2H-pyran-4-yl)ethanone
Similarity: 0.91
[ 5337-03-1 ]
Tetrahydropyran-4-yl-carboxylic acid
Similarity: 0.84
[ 85064-61-5 ]
Tetrahydropyranyl-4-acetic acid
Similarity: 0.83
[ 233276-38-5 ]
4-Methyltetrahydro-2H-pyran-4-carboxylic acid
Similarity: 0.81
[ 110238-91-0 ]
Methyl tetrahydro-2H-pyran-4-carboxylate
Similarity: 0.78